WHO ICTRP trial
Clinical study of Jiangzhi Xiaopi Decoction in the treatment of…
ChiCTR2400083810 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400083810 |
|---|---|
| Public title | Clinical study of Jiangzhi Xiaopi Decoction in the treatment of metabolism-related fatty liver disease (liver-depression and spleen-deficiency phenotype) |
| Scientific title | Clinical study of Jiangzhi Xiaopi Decoction in the treatment of metabolism-related fatty liver disease (liver-depression and spleen-deficiency phenotype) |
| Primary sponsor | Yueyang Hospital of Integrated Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Metabolism-related fatty liver disease |
| Interventions | Experimental group:Lifestyle intervention + oral dicycloxylic alcohol tablets + Jiangzhi Xiaopi Decoction add or subtract;Control group:Lifestyle intervention + oral dicycloxylic alcohol tablets |
| Registration date | May 5, 2024 |
| Target size | Experimental group:30;Control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: